Skip to content
drillr.ai
Sign up

UNCY

Unicycive Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$5.15
−2.82%
Ask drillr
0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-25.7%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 28, 2026Kenkare-Mitra Sara · directorA-Award47,941$0.00
Jul 28, 2026Laumas Sandeep · directorA-Award47,941$0.00
May 21, 2026Gupta Shalabh K. · director, officer: CEOA-Award762,200$0.00
May 21, 2026Kenkare-Mitra Sara · directorA-Award84,200$0.00
May 21, 2026Kenkare-Mitra Sara · directorA-Award42,100$0.00
May 20, 2026Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award169,500$0.00
May 20, 2026Jermasek Douglas · officer: EVP, Corporate StrategyA-Award169,500$0.00
May 20, 2026Townsend John · officer: CFOA-Award169,500$0.00
May 18, 2026Laumas Sandeep · directorA-Award42,100$0.00
May 18, 2026Laumas Sandeep · directorA-Award84,200$0.00
Jul 30, 2025Gupta Shalabh K. · director, officer: CEOA-Award325,000$4.71
Jul 30, 2025Jermasek Douglas · officer: EVP of Corporate StrategyA-Award10,000$4.71
Jul 30, 2025Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award90,000$4.71
Jul 30, 2025Townsend John · officer: Chief Financial OfficerA-Award10,000$4.71
Jul 30, 2025Laumas Sandeep · directorA-Award21,200$4.71
Jul 30, 2025Aggarwal Gaurav · directorA-Award21,200$4.71
Jul 30, 2025Kenkare-Mitra Sara · directorA-Award21,200$4.71
Aug 14, 2024Townsend John · officer: Chief Financial OfficerA-Award40,256$0.34
Aug 14, 2024Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award81,750$0.34
Aug 14, 2024Jermasek Douglas · officer: EVP of Corporate StrategyA-Award81,750$0.34
Aug 14, 2024Gupta Shalabh K. · director, officer: CEOA-Award232,868$0.34
Apr 17, 2024Gupta Pramod · officer: EVP, Pharmaceuticals and BDA-Award463,250$1.14
Apr 17, 2024Gupta Shalabh K. · director, 10 percent owner, officer: CEOA-Award1,319,583$1.14
Apr 17, 2024Townsend John · officer: Chief Financial OfficerA-Award228,119$1.14
Apr 17, 2024Jermasek Douglas · officer: EVP of Corporate StrategyA-Award463,250$1.14
Sep 7, 2023Kenkare-Mitra Sara · directorA-Award180,000$0.76
Sep 7, 2023Aggarwal Gaurav · directorA-Award180,000$0.76
Sep 7, 2023Laumas Sandeep · directorA-Award189,236$0.76
Sep 7, 2023Ryan John L · directorA-Award112,147$0.76
Aug 30, 2023Townsend John · officer: Chief Financial OfficerA-Award570,329$0.75
Institutional positioning

13F filings over the trailing two quarters

New 19Increased 12Reduced 11Sold out 51
FilerActionSharesFiled
VIVO CAPITAL, LLCUnchanged1,789,916May 20, 2026
MILLENNIUM MANAGEMENT LLCIncreased1,399,348May 15, 2026
OCTAGON CAPITAL ADVISORS LPUnchanged1,000,000May 15, 2026
NANTAHALA CAPITAL MANAGEMENT, LLCUnchanged939,202May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position811,430May 15, 2026
GREAT POINT PARTNERS LLCUnchanged796,558May 15, 2026
SUSQUEHANNA INTERNATIONAL GROUP, LLPIncreased598,319May 15, 2026
LOGOS GLOBAL MANAGEMENT LPUnchanged473,563May 15, 2026
CITADEL ADVISORS LLCIncreased344,741May 15, 2026
CITADEL ADVISORS LLCReduced301,368Sep 2, 2026
INTEGRAL HEALTH ASSET MANAGEMENT, LLCNew Position225,000May 15, 2026
GEODE CAPITAL MANAGEMENT, LLCIncreased203,744May 15, 2026
MORGAN STANLEYIncreased188,182May 15, 2026
JANE STREET GROUP, LLCIncreased156,143May 12, 2026
MARSHALL WACE, LLPNew Position154,938May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 28, 2026